SpinalCyte, LLC Competitors

Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists for bradykinin mediated diseases. Harnessing established science, the company aims to deliver oral bradykinin B2 receptor antagonists to help address unmet needs and improve standard of care. Our legacy, scientific expertise, and values drive our passion as we aspire to provide choice to people living with bradykinin-mediated diseases.

CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. Our revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, we are developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics. Our mission at CollPlant is to deliver ground-breaking products for regenerative medicine that offer the optimal treatment options to patients.

ViaCyte is now part of Vertex Pharmaceuticals. Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. For more information about Vertex, please visit us at https://www.vrtx.com/. Follow Vertex on LinkedIn for future updates at https://www.linkedin.com/company/vertex-pharmaceuticals/.